Amplyx Pharmaceuticals
San Diego
About Amplyx Pharmaceuticals
Amplyx Pharmaceuticals is a pre-clinical stage company focusing on the development of small molecule drugs with enhanced efficacy and lower toxicity. Amplyx employs a platform approach to improve small molecule drugs by the addition of a second small molecule to an existing drug. The company develops innovative therapies for debilitating and life-threatening diseases that affect people with compromised immune systems. Amplyx Pharmaceuticals was founded in 2006 and is headquartered in San Diego, California.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $198.4M
- Funding stage: M&A
- Last round: Series C (May 2020)
- Website: amplyx.com
- Phone: +118583484458
Industries & Categories
Biotechnology, Clinical Trials, Medical, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/amplyx-pharmaceuticals-43497 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.